Covishield
-
Bihar announces free vaccination for all above 18 years of age
India | Apr 21, 2021, 08:41 PM ISTBihar government will run a free vaccination drive against coronavirus for people above 18 years of age, Bihar Chief Minister Nitish Kumar informed on Wednesday.
-
0.04 % tested Covid positive after second dose of Covaxin, 0.03% after Covishield: Govt data
India | Apr 21, 2021, 06:56 PM ISTMore than 21,000 people tested positive for COVID-19 after taking the first dose of either Covishield or Covaxin, while over 5,500 contracted the infection after taking the second dose, the Centre said on Wednesday.
-
Covishield comprises over 90% of 12.76 crore Covid vaccines administered so far
India | Apr 21, 2021, 04:22 PM ISTCovishield, from the Oxford/AstraZeneca stable, comprises over 90 per cent of the 12.76 crore COVID-19 vaccines administered across the country so far, according to government data on Wednesday.
-
When will Covishield be available at medical stores? Serum Institute answers
India | Apr 21, 2021, 02:05 PM ISTSII said the Covishield vaccine will be available to state governments for Rs 400 per dose and to private hospitals at Rs 600 per dose.
-
Covaxin neutralises double mutant strain of Covid-19: ICMR
India | Apr 21, 2021, 01:58 PM ISTICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well.
-
Serum Institute to provide Covishield at Rs 600 per dose to private hospitals, Rs 400 to states
India | Apr 21, 2021, 01:50 PM ISTThe Serum Institute of India has said that it will provide Covishield to private hospitals for Rs 600 per dose. It will charge the state governments Rs 400 for per dose of the Covid-19 vaccine.
-
'Understand India's pharmaceutical needs': US to consider lifting ban on vaccine raw material supply
World | Apr 20, 2021, 02:50 PM ISTThe Biden administration has conveyed to India that they understand India's pharmaceutical requirements and has promised to review embargo on Covid-19 vaccine raw material.
-
Govt to provide Rs 4,500 cr booster to SII, Bharat Biotech for ramping up Covid vaccine production
India | Apr 20, 2021, 12:30 PM ISTCOVID-19 vaccine: SII will supply 200 million doses and Bharat Biotech is to supply another 90 million doses to the government by July at a pre-agreed rate of Rs 150 per dose.
-
No dearth of Covid-19 vaccine, ramping up Remdesivir production: Harsh Vardhan
India | Apr 14, 2021, 05:38 PM ISTCurrently, two Covid-19 vaccines -- Covaxin and Covishield are being used for inoculation in the country. India has just granted permission for emergency use of Russia's Sputnik V vaccine.
-
COVID-19 vaccines in India: In a nutshell
India | Apr 13, 2021, 10:21 PM ISTThe Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin.
-
Centre fast-tracks approval for foreign-produced Covid-19 vaccines to push inoculation drive
India | Apr 13, 2021, 04:29 PM ISTTwo Covid-19 vaccines -- Covaxin and Covishield are being used for inoculation in India. India has just granted permission for emergency use of Russia's Sputnik V vaccine.
-
India to produce 850 Million Sputnik V doses annually: RDIF
India | Apr 13, 2021, 12:09 PM ISTThe Drug Controller General of India (DCGI) has registered the vaccine under the emergency use authorisation procedure.
-
Bus carrying Covid vaccine breaks down outside Patna airport
News | Apr 09, 2021, 06:40 PM ISTA transport vehicle dedicated to deliver vials of Covid-19 vaccine to a storage centre at the Nalanda Medical College Hospital (NMCH), broke down just as it was leaving the airport.
-
Seychelles President thanks India for 'precious' donation of COVID vaccines
News | Apr 08, 2021, 10:43 PM ISTPresident of Seychelles, Wavel Ramkalawan during a virtual meet with Prime Minister Narendra Modi thanked him for solidarity and contribution in fight against COVID-19 by donating 50,000 doses of Covishield vaccine.
-
WHO rejects Serum Institute's proposal seeking extension of Covishield's shelf life to 9 months
World | Apr 08, 2021, 08:03 PM ISTThe WHO has rejected Serum Institute of India's proposal seeking extension of the shelf life of Oxford-AstraZeneca COVID-19 vaccine, Covishield, from six to nine months, citing insufficient data, sources said.
-
AstraZeneca legal notice to Serum Institute over delays
India | Apr 08, 2021, 09:34 AM ISTPoonawalla has mentioned that the existing production capacity to manufacture Covishield in India is under pressure due to increased demand in India.
-
Third phase of Covid-19 vaccination for all above 45 years from today
India | Apr 02, 2021, 09:30 AM ISTThe third phase of Covid-19 vaccination drive will include those who are above 45 years. People can book an appointment for COVID-19 vaccination via CoWIN. Beneficiaries can also go for on-site registration.
-
DCGI extends shelf life of Covishield from 6 to 9 months
India | Mar 31, 2021, 12:51 PM ISTDCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from 6 to 9 months.
-
Asaduddin Owaisi takes first dose of Covishield at Hyderabad hospital
India | Mar 22, 2021, 04:28 PM ISTAsaduddin Owaisi on Monday received the first dose of Covid-19 vaccine, Covishield. Covishield is the Indian version of the AstraZeneca-Oxford drug.
-
Govt revises dose interval for Oxford-AstraZeneca's Covishield vaccine upto 8 weeks
India | Mar 22, 2021, 04:50 PM ISTThe government on Monday revised the interval between two doses of Oxford-AstraZeneca's Covishield vaccine.